Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29879125 | 1.00 | PDE4A (0.43) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| SCHEMBL4280412 | 0.87 | PDE4A (0.37) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| SCHEMBL6813499 | 0.80 | LMNA (0.42) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| SCHEMBL2773023 | 0.79 | PDE4A (0.43) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| SCHEMBL31542046 | 0.79 | LMNA (0.36) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| SCHEMBL9763747 | 0.78 | USP2 (0.48) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| SCHEMBL29159266 | 0.78 | USP2 (0.48) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| SCHEMBL8465616 | 0.78 | PDE4A (0.46) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| SCHEMBL18825609 | 0.78 | USP2 (0.48) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 | |
| SCHEMBL8356023 | 0.77 | USP2 (0.47) | PDE4ALMNAUSP2SLCO1B1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1227789-B1 | IMPROVED DUAL PHASE STANNOUS ORAL COMPOSITIONS | PROCTER & GAMBLE (US) | 2004-09-22 | — | — | EP | claimed |
| CN-115337242-A | Traditional Chinese medicine composition, extract, preparation method and application thereof, cosmetics and medicines | 新生活化妆品科技(上海)有限公司 | 2022-11-15 | — | — | CN | disclosed |
| EP-1227789-B1 | IMPROVED DUAL PHASE STANNOUS ORAL COMPOSITIONS | PROCTER & GAMBLE (US) | 2004-09-22 | — | — | EP | disclosed |
| EP-1227789-A1 | IMPROVED DUAL PHASE STANNOUS ORAL COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2002-08-07 | — | — | EP | disclosed |
| WO-2001034109-A1 | IMPROVED DUAL PHASE STANNOUS ORAL COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-05-17 | — | — | WO | disclosed |